{"filings":[{"id":104572,"accession_number":"0001493712-26-000006","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2026-03-20T23:59:59+00:00","items":["1.01","3.02","7.01","1.1","9.01"],"status":"ready","headline":"StimCell Energetics engages Stonegate Capital Partners for research coverage; issues 250,000 shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stonegate will provide quarterly research, IR consultation, and institutional investor meetings for 12-month term.","Compensation: 250,000 shares of common stock issued under Rule 506(b) to accredited investor Stonegate.","Shares subject to 6-month hold period in Canada and restricted under U.S. securities laws.","Company seeks to boost institutional ownership and visibility for its eBalance technology."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120844,"accession_number":"0001493712-25-000005","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2025-12-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"StimCell signs research agreement with St. Boniface Hospital to study eBalance on mitochondrial function","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Service agreement with St. Boniface Hospital Albrechtsen Research Centre, effective Dec 1, 2025.","Study will examine eBalance® microcurrent device effects on mitochondrial function in sensory neurons.","Principal Investigator Prof. Paul Fernyhough; project expected to last approximately three months.","Measurements include oxygen consumption rates, ATP production, glycolysis, and enzyme activities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173285,"accession_number":"0001139020-25-000008","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2025-03-28T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"StimCell Energetics settles $15K debt with shares, engages Rain Communications for IR, and previews eBalance redesign","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Settled $15,000 debt via 75,000 common shares at $0.20 per share.","Engaged Rain Communications for eight-month IR; will receive 125,000 shares/month at $0.20 each.","eBalance redesign v1 revealed: smaller device with custom iOS/Android app for personalized treatment tracking.","Shares issued under Regulation S and Rule 506(b); four-month hold period in Canada."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173284,"accession_number":"0001393905-25-000075","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"StimCell Energetics partners with ADM Tronics to redesign eBalance device for home use","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Partnership with ADM Tronics (OTCQB: ADMT) to redesign eBalance microcurrent device for home use.","Redesigned unit will be smaller, cost-effective, and include real-time cellular energy diagnostics, treatment tracking, and personalized profiles.","eBalance uses non-invasive frequency-specific microcurrent to stimulate ATP production for anti-aging, pain relief, and vitality.","CEO David Jeffs says redesign aims to make cellular energy optimization accessible for home users."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173283,"accession_number":"0001393905-25-000013","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2025-01-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"StimCell Energetics engages Think Ink Marketing for six-month investor outreach","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Signs marketing services agreement with Think Ink Marketing Data & Email Services, Inc.","Agreement runs six months; either party may terminate with 30 days' notice.","Budget up to $10,000 per month for online banners and native ads.","Company completed rebranding; now trades under symbol STME on OTC.","Think Ink is a California-based marketing firm established in 1991."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190302,"accession_number":"0001393905-24-000378","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2024-11-05T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Cell MedX completes 1:15 reverse stock split and rebrands as Stimcell Energetics","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split 1:15 effective Nov 1, 2024; shares outstanding reduced from ~297M to ~19.8M.","Authorized capital reduced from 7.5B to 500M shares of common, par value $0.001.","Name changed from Cell MedX Corp. to Stimcell Energetics Inc.","Symbol will trade as \"CMXCD\" for 20 business days starting Nov 5, then seek new symbol.","New website launched at www.StimCell.com for investor and clinical trial info."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224054,"accession_number":"0001393905-24-000114","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2024-04-04T23:59:59+00:00","items":["3.02","5.03","9.01"],"status":"ready","headline":"Cell MedX elects four directors and increases authorized shares to 7.5B","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected directors: David Jeffs, George Adams, Joao (John) Da Costa, Amir Vahabzadeh effective April 1, 2024.","Authorized common stock increased from 300M to 7.5B shares ($0.001 par value).","Increase approved by written consent of stockholders holding 66% of outstanding shares.","No other material corporate changes were disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243418,"accession_number":"0001393905-24-000085","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2024-03-19T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Cell MedX closes $75k private placement; director and spouse subscribe $30k","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 2,500,000 units at $0.03/unit for gross proceeds of $75,000.","Each unit includes one common share and one warrant (exp. March 12, 2026).","Warrant exercise price: $0.04/share until Sep 12, 2024, then $0.05 thereafter.","Director Amir Vahabzadeh and his spouse acquired 1,000,000 units ($30,000).","Offering exempt under Reg S and Rule 506(b); securities unregistered."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243417,"accession_number":"0001393905-24-000057","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2024-02-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cell MedX director Brad Hargreaves resigns from board, no disagreement cited","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brad Hargreaves resigned from Cell MedX's Board of Directors effective February 27, 2024.","Resignation not due to any disagreement with the Company's operations, policies, or practices.","Cell MedX has not yet filled the vacancy left by Hargreaves' departure.","Company thanked Hargreaves for his contributions and wished him success."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260808,"accession_number":"0001393905-23-000412","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2023-12-19T23:59:59+00:00","items":["3.02","5.01","5.02","9.01"],"status":"ready","headline":"Cell MedX settles $1.62M debt with 231.8M shares at $0.007; new CEO David Jeffs appointed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dwayne Yaretz resigns as CEO, Brad Hargreaves resigns as VP of Tech & Ops; both remain directors.","David Jeffs appointed new CEO; Jeffs and Amir Vahabzadeh appointed to the board.","Debt of $1,622,693 settled with 231,813,310 shares at $0.007/share.","Post-settlement, Jeffs and family hold ~40%; Vahabzadeh and spouse hold ~29% of shares.","Completion of debt settlement will result in a change in control of Cell MedX."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260807,"accession_number":"0001393905-23-000387","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2023-11-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cell MedX Corp. Announces Revocation of British Columbia Cease Trade Order","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["BCSC revoked cease trade order on Nov 22, 2023, originally issued Oct 11, 2022 for missing filings.","Company filed audited financials for years ended May 31, 2023 and 2022 and related interim periods.","Company is now up to date with continuous disclosure obligations under Canadian securities laws.","Correction: prior news release incorrectly stated Mr. da Costa was independent; he is not under NI 52-110.","Audit committee comprises Mr. da Costa, Mr. Adams, and CEO Dwayne Yaretz."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260806,"accession_number":"0001393905-23-000367","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2023-11-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cell MedX COO resigns, stays as director; audit committee appointed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joao da Costa resigned as COO on Nov 7, 2023; continues as director.","Audit committee formed with Dwayne Yaretz (CEO), George Adams, and Joao da Costa.","Adams and da Costa are independent per NI 52-110; Yaretz is not independent.","All three members are financially literate and qualify as audit committee financial experts."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":334924,"accession_number":"0001393905-22-000425","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2022-10-18T23:59:59+00:00","items":["1.01","7.01","8.01","9.01"],"status":"ready","headline":"Cell MedX gets BCSC cease trade order, grants security over eBalance IP on ~$539k loan","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["BCSC issued cease trade order on Oct 11, 2022 for failing to file annual financial statements due to insufficient audit funds.","Consolidated ~$539,325 in loans from major shareholder Richard Jeffs; granted security interest over eBalance Technology and IP on default.","Loans remain due on demand with 6% annual interest compounded monthly; no revenue from eBalance Systems yet.","Company cannot assure it will raise necessary funding to remedy filing defaults or complete the audit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":369906,"accession_number":"0001393905-22-000125","cik":1493712,"company_name":"Stimcell Energetics Inc.","ticker":"STME","form_type":"8-K","filed_at":"2022-04-27T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cell MedX appoints Dwayne Yaretz as CEO; former CEO McEnulty remains director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dwayne Yaretz appointed CEO and to the board on April 25, 2022, replacing Mr. McEnulty as CEO.","Mr. McEnulty resigned as CEO but continues to serve as a director of Cell MedX.","Yaretz has experience in medical imaging devices and corporate restructuring.","No compensation arrangements for Yaretz as CEO or director have been disclosed.","Yaretz aims to advance eBalance Systems Health Canada approvals and seek FDA 510K clearance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":6765207.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}